These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4610921)

  • 21. Mechanism of long term survival of renal allografts after treatment with antilymphocyte antibody.
    Guttmann RD; Lindquist RR; Ockner SA; Merrill JP
    Transplant Proc; 1969 Mar; 1(1):463-6. PubMed ID: 4944260
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
    Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
    [No Abstract]   [Full Text] [Related]  

  • 23. Rejection of renal allografts: specific immunologic suppression.
    Stuart FP; Saitoh T; Fitch FW
    Science; 1968 Jun; 160(3835):1463-5. PubMed ID: 4871383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The capacity of lymphocytes from rats bearing enhanced kidney allografts to mount graft-versus-host reactions.
    French ME; Batchelor JR; Watts HG
    Transplantation; 1971 Jul; 12(1):45-8. PubMed ID: 4397366
    [No Abstract]   [Full Text] [Related]  

  • 25. Cellular and humoral immunity after allogeneic transplantation in the rat. II. Comparison of a 51Cr release assay and modified microcytotoxicity assay for detection of cellular immunity and blocking serum factors.
    Biesecker JL; Fitch FW; Rowley DA; Scollard D; Stuart FP
    Transplantation; 1973 Nov; 16(5):421-31. PubMed ID: 4584952
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of sheep antilymphocyte plasma on the survival of dog renal allografts.
    Fox M; Diethelm AG; Orr WM; Dammin GJ; Glassock RJ; Murray JE
    Proc R Soc Med; 1968 Sep; 61(9):877-80. PubMed ID: 4878256
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhancement of skin allograft survival by soluble alloantigen is serum-mediated.
    Rao VS; Bonavida B
    Transplantation; 1976 Jan; 21(1):42-50. PubMed ID: 1108325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular requirements for first-set renal allograft rejection.
    Bolton EM; Armstrong HE; Briggs JD; Bradley JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):321-3. PubMed ID: 3274781
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization.
    Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB
    Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification of the rat alloimmune response by enhancing antibodies and the role of blocking factors in the survival of renal grafts.
    Strom TB; Carpenter CB; Garovoy MR; Abbas AK; Corson JM; Bear RA; Soulillou JP
    Transplantation; 1975 Nov; 20(5):368-80. PubMed ID: 1108311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Passive antibody delays development of cell-mediated immunity in rats receiving renal allografts.
    Biesecker JL; Fitch FW; Rowley DA; Stuart FP
    Transplant Proc; 1973 Mar; 5(1):667-9. PubMed ID: 4572125
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperacute rejection and enhancement of rabbit-kidney allografts.
    McDowall RA; Batchelor JR; French ME
    Lancet; 1973 Apr; 1(7807):797-801. PubMed ID: 4121222
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolongation of skin allograft survival with antilymphocyte serum and soluble histocompatibility antigens.
    Sumerska T; Betel I; Balner H; Warren HS
    Transplantation; 1974 Jan; 17(1):1-7. PubMed ID: 4148888
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunologic enhancement of rat renal allografts. I. Comparative morphology of acutely rejecting and passively enhanced grafts.
    Abbas AK; Corson JM; Carpenter CB; Galvanek EG; Merrill JP; Dammin GJ
    Am J Pathol; 1974 May; 75(2):255-70. PubMed ID: 4595938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of anti-donor serum (ADS) and donor cells on renal allograft survival in DL-A tissue-typed littermate beagles.
    Jeekel J; Obertop H; Vriesendorp HM; McDicken I; Westbroek DL
    Transplant Proc; 1975 Sep; 7(3):435-8. PubMed ID: 1099744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation tolerance and enhancement. Concepts and questions.
    Elkins WL; Hellström I; Hellström KE
    Transplantation; 1974 Jul; 18(1):38-45. PubMed ID: 4151912
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppression of rejection of organ allografts by alloantibody.
    Morris PJ
    Immunol Rev; 1980; 49():93-125. PubMed ID: 6445324
    [No Abstract]   [Full Text] [Related]  

  • 39. Rejection and enhancement in an in vitro model of alloimmunity.
    Strom TB; Carpenter CB; Phillips SM; Garovoy MR; Merrill JP
    Transplantation; 1973 Aug; 16(2):103-9. PubMed ID: 4581397
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphocyte-dependent antibody and renal graft rejection.
    Stiller CR; Sinclair NR; Abrahams S; Ulan RA; Fung M; Wallace AC
    Lancet; 1975 Apr; 1(7913):953-4. PubMed ID: 48125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.